Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

WNT Pathway: early-phase trial registry

1 of 1 indexed WNT Pathway trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

WNT Pathway: 1 US clinical trial tracked, 1 recruiting.

WNT Pathway is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Parabilis Medicines, running 1 of these trials.

Enrollment posture brief

Registry condition wnt-pathway

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

WNT Pathway (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near WNT Pathway

WNT Pathway lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for WNT Pathway on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. WNT Pathway is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on WNT Pathway records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Trifluridine/tipiracil Drug
1 trials
mFOLFOX-6 Drug
1 trials
FOG-001 Drug
1 trials
Nivolumab Drug
1 trials
Bevacizumab Drug
1 trials

US sites by state

Facility locations filed on WNT Pathway trials. A trial with sites in several states counts in each.

Texas 1 trials
Tennessee 1 trials
Pennsylvania 1 trials
Oregon 1 trials
Ohio 1 trials
New York 1 trials
Missouri 1 trials
Minnesota 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this WNT Pathway page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This WNT Pathway condition card totals 1 registered trials; most-linked intervention Trifluridine/tipiracil; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.